Literature DB >> 24488515

A double robust approach to causal effects in case-control studies.

Sherri Rose, Mark van der Laan.   

Abstract

In a recent issue of the Journal, VanderWeele and Vansteelandt (Am J Epidemiol. 2011;174(10):1197-1203) discussed an inverse probability weighting method for case-control studies that could be used to estimate an additive interaction effect, referred to as the "relative excess risk due to interaction." In this article, we reinforce the well-known disadvantages of inverse probability weighting and comment on the desirability of the described parameter. Further, we review an existing double robust estimator not considered by VanderWeele and Vansteelandt, the case-control-weighted targeted maximum likelihood estimator, which has improved properties in comparison with a previously described inverse-probability-weighted estimator. This targeted maximum likelihood estimator can be used to target various parameters of interest, and its implementation has been described previously for the risk difference, relative risk, and odds ratio.

Keywords:  case-control studies; causality; epidemiologic methods; estimation techniques

Mesh:

Year:  2014        PMID: 24488515      PMCID: PMC3939846          DOI: 10.1093/aje/kwt318

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  30 in total

1.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Authors:  Miguel A Hernán; Babette A Brumback; James M Robins
Journal:  Stat Med       Date:  2002-06-30       Impact factor: 2.373

2.  Collaborative targeted maximum likelihood for time to event data.

Authors:  Ori M Stitelman; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  Why match? Investigating matched case-control study designs with causal effect estimation.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2009-01-06       Impact factor: 0.968

4.  A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix.

Authors:  J CORNFIELD
Journal:  J Natl Cancer Inst       Date:  1951-06       Impact factor: 13.506

5.  A targeted maximum likelihood estimator for two-stage designs.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-11       Impact factor: 0.968

6.  A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome.

Authors:  Susan Gruber; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010-08-01       Impact factor: 0.968

7.  Finding Quantitative Trait Loci Genes with Collaborative Targeted Maximum Likelihood Learning.

Authors:  Hui Wang; Sherri Rose; Mark J van der Laan
Journal:  Stat Probab Lett       Date:  2011-07-01       Impact factor: 0.870

8.  Population intervention causal effects based on stochastic interventions.

Authors:  Iván Díaz Muñoz; Mark van der Laan
Journal:  Biometrics       Date:  2011-10-06       Impact factor: 2.571

9.  Accounting for perception, placebo and unmasking effects in estimating treatment effects in randomised clinical trials.

Authors:  Farid Jamshidian; Alan E Hubbard; Nicholas P Jewell
Journal:  Stat Methods Med Res       Date:  2011-09-08       Impact factor: 2.494

10.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

View more
  10 in total

1.  Invited commentary: Some advantages of the relative excess risk due to interaction (RERI)--towards better estimators of additive interaction.

Authors:  Tyler J VanderWeele; Stijn Vansteelandt
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

2.  Rose and van der Laan respond to "Some advantages of the relative excess risk due to interaction".

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

3.  Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes.

Authors:  Wi-Sun Ryu; Dawid Schellingerhout; Keun-Sik Hong; Sang-Wuk Jeong; Beom Joon Kim; Joon-Tae Kim; Kyung Bok Lee; Tai Hwan Park; Sang-Soon Park; Jong-Moo Park; Kyusik Kang; Yong-Jin Cho; Hong-Kyun Park; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Soo Joo Lee; Jae Guk Kim; Jae-Kwan Cha; Dae-Hyun Kim; Jun Lee; Moon-Ku Han; Man Seok Park; Kang-Ho Choi; Matthias Nahrendorf; Juneyoung Lee; Hee-Joon Bae; Dong-Eog Kim
Journal:  Ann Neurol       Date:  2021-10-05       Impact factor: 11.274

4.  Matching and Imputation Methods for Risk Adjustment in the Health Insurance Marketplaces.

Authors:  Sherri Rose; Julie Shi; Thomas G McGuire; Sharon-Lise T Normand
Journal:  Stat Biosci       Date:  2015-08-05

5.  Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population.

Authors:  Ibrahim Abdollahpour; Saharnaz Nedjat; Mohammad Ali Mansournia; Tibor Schuster
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

6.  Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips.

Authors:  Tomohiro Shinozaki; Etsuji Suzuki
Journal:  J Epidemiol       Date:  2020-07-18       Impact factor: 3.211

7.  Evaluating the heterogeneous effect of a modifiable risk factor on suicide: The case of vitamin D deficiency.

Authors:  Jose R Zubizarreta; John C Umhau; Patricia A Deuster; Lisa A Brenner; Andrew J King; Maria V Petukhova; Nancy A Sampson; Boris Tizenberg; Sanjaya K Upadhyaya; Jill A RachBeisel; Elizabeth A Streeten; Ronald C Kessler; Teodor T Postolache
Journal:  Int J Methods Psychiatr Res       Date:  2021-11-05       Impact factor: 4.035

8.  The causal effect and impact of reproductive factors on breast cancer using super learner and targeted maximum likelihood estimation: a case-control study in Fars Province, Iran.

Authors:  Amir Almasi-Hashiani; Saharnaz Nedjat; Reza Ghiasvand; Saeid Safiri; Maryam Nazemipour; Nasrin Mansournia; Mohammad Ali Mansournia
Journal:  BMC Public Health       Date:  2021-06-24       Impact factor: 3.295

9.  Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research.

Authors:  Menglan Pang; Tibor Schuster; Kristian B Filion; Maria Eberg; Robert W Platt
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

10.  Anticholinergic drugs and risk of dementia: case-control study.

Authors:  Kathryn Richardson; Chris Fox; Ian Maidment; Nicholas Steel; Yoon K Loke; Antony Arthur; Phyo K Myint; Carlota M Grossi; Katharina Mattishent; Kathleen Bennett; Noll L Campbell; Malaz Boustani; Louise Robinson; Carol Brayne; Fiona E Matthews; George M Savva
Journal:  BMJ       Date:  2018-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.